Detalles de la búsqueda
1.
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.
J Clin Rheumatol
; 28(2): e407-e414, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33902098
2.
Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis.
J Clin Rheumatol
; 28(2): 69-76, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741000
3.
Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis.
Eur J Clin Pharmacol
; 75(10): 1431-1443, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270563
4.
Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting risks earlier.
Eur J Clin Pharmacol
; 70(6): 745-56, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24691786
5.
Sources of information used by regulatory agencies on the generation of drug safety alerts.
Eur J Clin Pharmacol
; 69(12): 2083-94, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23893047
6.
Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions.
J Nurs Manag
; 19(3): 395-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21507111
7.
Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade.
J Ocul Pharmacol Ther
; 31(5): 258-68, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25871404
8.
Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel.
Pharmacoepidemiol Drug Saf
; 14(12): 885-90, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16059869
Resultados
1 -
8
de 8
1
Próxima >
>>